Former Georgia Congressman Doug Collins recently published an opinion piece in the Atlanta Journal-Constitution on how 11 years of ill-informed Supreme Court decisions have substantially weakened IP rights and set back American innovation — and how the Patent Eligibility Restoration Act would remedy this problem to revitalize numerous high-tech industries.
Collins explains how rulings like Alice Corp. vs. CLS Bank International and Association for Molecular Pathology vs. Myriad Genetics limited patent eligibility for novel technologies like artificial intelligence and gene therapies, creating confusion that has disincentivized innovation in those areas.
He argues that the Patent Eligibility Restoration Act would address this problem by explicitly identifying which technologies are patent-eligible, removing uncertainty and restoring support for American inventors.
“By unwinding the negative impact of confusing judicial decisions, the Patent Eligibility Restoration Act would strengthen the U.S. intellectual property system, protect innovators, and shore up our ability to compete with geopolitical rivals.”
Read the full op-ed here: